Job Summary

• Provide clinical and scientific leadership for potential new, established and emerging indications for assets in clinical development with a strong focus on neurodegenerative disease including Alzheimer’s Dementia (AD).
• Lead the clinical development strategy from a drug or program including accountability for the clinical components of the Target Medicine Profile (TMP) and leadership of the clinical matrix team (CMT).
• This position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role.

Matching Summary

Salary

Base: $284,625 to $474,375; Bonus/Equity: annual bonus and long-term incentive program; Benefits: health care, retirement, paid time off

Skills & Requirements

Key Requirements

• Medical degree and clinical medical specialty training board qualification/registration
• Experience in global pharmaceutical/biotechnology industry in Neurodegeneration
• Experience in late-stage neurodegeneration drug development (Phase 2/3)
• Experience leading NDA, BLA, or MAA submissions
• Matrix team leadership experience

Work Rights